Motorola Solutions
MSI
448.33
-7.95
-1.74%
Motorola Solutions
US · MSI
#299 by market cap
Listed 1970
448.33
-7.95
-1.74%
Live - 5344 symbols - heartbeat 31s ago
· 2026-10-08 08:34
Pre-market
448.33
0.00%
After-hours
447.51
-0.18%
- Market cap
- 74.20B
- P/E (TTM)i
- 35.33
- P/Bi
- 27.77
- EPSi
- 12.75
- Div yieldi
- 1.05%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on MSI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.93, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.00% YoY
Margins
- Gross margin
- 51.66%
- Operating margin
- 25.33%
- Net margin
- 18.44%
Key ratios & quality
- Enterprise valuei
- 82.33B
- PEG ratioi
- 2.14
- Altman Z-Scorei
- 3.93
PEG uses trailing P/E against the 3-year net income growth rate (16.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.34B | 7.89B | 7.41B | 8.17B | 9.11B | 9.98B | 10.82B | 11.68B |
| Gross profit | 3.48B | 3.93B | 3.61B | 4.04B | 4.23B | 4.97B | 5.51B | 6.04B |
| Selling & admin expenses | 1.25B | 1.40B | 1.29B | 1.35B | 1.45B | 1.56B | 1.75B | 1.87B |
| Research & development | 637.00M | 687.00M | 686.00M | 734.00M | 779.00M | 858.00M | 917.00M | 970.00M |
| Operating profit | 1.34B | 1.63B | 1.41B | 1.72B | 1.74B | 2.36B | 2.69B | 2.96B |
| Pretax profit | 1.10B | 1.00B | 1.17B | 1.55B | 1.52B | 2.15B | 1.97B | 2.81B |
| Tax | 133.00M | 130.00M | 221.00M | 302.00M | 148.00M | 432.00M | 390.00M | 652.00M |
| Net profit | 969.00M | 871.00M | 953.00M | 1.25B | 1.37B | 1.71B | 1.58B | 2.16B |
| Basic EPS | 6 | 5 | 6 | 7 | 8 | 10 | 9 | 13 |
| Diluted EPS | 5.62 | 4.95 | 5.45 | 7.17 | 7.93 | 9.93 | 9.23 | 12.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.77B | 3.01B | 3.38B | 2.71B | 3.13B |
| Gross profit | 1.30B | 1.41B | 1.55B | 1.77B | 1.36B | 1.68B |
| Selling & admin expenses | 436.00M | 450.00M | 485.00M | 499.00M | 439.00M | 496.00M |
| Research & development | 233.00M | 231.00M | 237.00M | 270.00M | 252.00M | 260.00M |
| Operating profit | 594.00M | 693.00M | 766.00M | 905.00M | 581.00M | 827.00M |
| Pretax profit | 547.00M | 680.00M | 725.00M | 860.00M | 441.00M | 742.00M |
| Tax | 115.00M | 165.00M | 161.00M | 210.00M | 73.00M | 184.00M |
| Net profit | 432.00M | 515.00M | 564.00M | 650.00M | 368.00M | 558.00M |
| Basic EPS | 3 | 3 | 3 | 4 | 2 | 3 |
| Diluted EPS | 2.53 | 3.04 | 3.33 | 3.86 | 2.18 | 3.33 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.27B | 4.18B | 4.33B | 5.41B | 5.26B | 5.73B | 6.48B | 6.30B |
| Cash & ST investments | 1.26B | 1.00B | 1.25B | 1.87B | 1.33B | 1.71B | 2.10B | 1.16B |
| Inventory | 356.00M | 447.00M | 508.00M | 788.00M | 1.06B | 827.00M | 766.00M | 983.00M |
| Total assets | 9.41B | 10.64B | 10.88B | 12.19B | 12.81B | 13.34B | 14.60B | 19.39B |
| Total current liabilities | 3.10B | 3.44B | 3.49B | 4.06B | 4.56B | 5.74B | 5.06B | 6.08B |
| Short-term debt | 31.00M | 138.00M | 138.00M | 129.00M | 119.00M | 1.44B | 449.00M | 882.00M |
| Long-term debt | 5.29B | 5.11B | 5.16B | 5.69B | 6.01B | 4.71B | 5.68B | 8.41B |
| Total liabilities | 10,685,000,000.00 | 11,325,000,000.00 | 11,417,000,000.00 | 12,212,000,000.00 | 12,683,000,000.00 | 12,597,000,000.00 | 12,876,000,000.00 | 16,962,000,000.00 |
| Total equity | -1.28B | -683.00M | -541.00M | -23.00M | 131.00M | 739.00M | 1.72B | 2.43B |
| Retained earnings | 1.05B | 1.24B | 1.13B | 1.35B | 1.34B | 1.64B | 2.30B | 2.55B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 5.90B | 7.71B | 5.81B | 6.30B | 5.95B | 6.13B |
| Cash & ST investments | 1.56B | 3.21B | 894.00M | 1.16B | 886.00M | 710.00M |
| Inventory | 833.00M | 861.00M | 943.00M | 983.00M | 1.18B | 1.33B |
| Total assets | 14.43B | 16.41B | 18.80B | 19.39B | 19.08B | 19.24B |
| Total current liabilities | 4.92B | 4.46B | 5.66B | 6.08B | 5.56B | 5.58B |
| Short-term debt | 436.00M | 199.00M | 1.06B | 882.00M | 680.00M | 760.00M |
| Long-term debt | 5.68B | 7.66B | 8.41B | 8.41B | 8.42B | 8.42B |
| Total liabilities | 12,774,000,000.00 | 14,428,000,000.00 | 16,455,000,000.00 | 16,962,000,000.00 | 16,517,000,000.00 | 16,554,000,000.00 |
| Total equity | 1.66B | 1.98B | 2.34B | 2.43B | 2.56B | 2.69B |
| Retained earnings | 2.22B | 2.34B | 2.59B | 2.55B | 2.60B | 2.63B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.08B | 1.82B | 1.61B | 1.84B | 1.82B | 2.04B | 2.39B | 2.84B |
| Depreciation & amortization | 360.00M | 394.00M | 409.00M | 438.00M | 440.00M | 356.00M | 336.00M | 425.00M |
| Free cash flow | 878.00M | 1.58B | 1.40B | 1.59B | 1.57B | 1.79B | 2.13B | 2.57B |
| Dividends paid | -337.00M | -379.00M | -436.00M | -482.00M | -530.00M | -589.00M | -654.00M | -728.00M |
| Stock buybacks / issuance | 36.00M | -201.00M | -504.00M | -426.00M | -680.00M | -700.00M | -172.00M | -1.11B |
| Ending cash balance | 1.26B | 1.00B | 1.25B | 1.87B | 1.33B | 1.71B | 2.10B | 1.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 510.00M | 273.00M | 798.00M | 1.26B | 451.00M | 469.00M |
| Depreciation & amortization | 81.00M | 86.00M | 115.00M | 143.00M | 143.00M | 148.00M |
| Free cash flow | 473.00M | 225.00M | 732.00M | 1.14B | 389.00M | 414.00M |
| Dividends paid | -182.00M | -182.00M | -182.00M | -182.00M | -201.00M | -201.00M |
| Stock buybacks / issuance | -415.00M | -165.00M | -87.00M | -441.00M | -124.00M | -334.00M |
| Ending cash balance | 1.56B | 3.21B | 894.00M | 1.17B | 886.00M | 710.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | 3,586.84 | 406.90 | 129.95 | 104.74 |
| ROA %i | 10.97 | 8.66 | 8.82 | 10.80 | 10.90 | 13.07 | 11.29 | 12.68 |
| ROIC %i | -- | -- | -- | -- | 24.56 | 26.99 | 22.66 | 23.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.28 | 15.70 | 18.98 | 21.63 | 19.26 | 24.00 | 20.96 | 27.15 |
| FCF / sales %i | 11.96 | 19.97 | 18.83 | 19.51 | 17.20 | 17.95 | 19.73 | 22.02 |
| Current ratioi | 1.38 | 1.21 | 1.24 | 1.33 | 1.15 | 1.00 | 1.28 | 1.04 |
| Quick ratioi | 1.20 | 1.03 | 1.04 | 1.09 | 0.85 | 0.80 | 1.05 | 0.82 |
| Debt / assetsi | 56.54 | 54.01 | 52.44 | 50.29 | 51.12 | 49.12 | 44.89 | 50.37 |
| LT debt / equityi | -- | -- | -- | -- | 5,544.83 | 706.08 | 358.31 | 368.63 |
| Interest coveragei | 5.59 | 5.22 | 6.04 | 8.22 | 7.31 | 9.62 | 7.68 | 8.81 |
| Revenue CAGR (3Y) %i | 8.84 | 9.31 | 5.13 | 3.63 | 4.93 | 10.41 | 9.80 | 8.63 |
| Net income CAGR (3Y) %i | 16.56 | 15.73 | -- | 8.83 | 16.23 | 21.66 | 8.20 | 16.48 |
| FCF CAGR (3Y) %i | 1.25 | 20.78 | 7.65 | 21.99 | -0.17 | 8.66 | 10.21 | 17.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 189.27 | 152.78 | 115.85 | 104.74 | 99.88 | 91.98 |
| ROA %i | 14.74 | 14.22 | 12.95 | 12.68 | 12.47 | 11.97 |
| ROIC %i | 28.66 | 25.49 | 22.90 | 23.36 | 23.30 | 21.66 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.58 | 27.00 | 27.02 | 27.15 | 26.19 | 26.22 |
| FCF / sales %i | 20.73 | 21.49 | 21.34 | 22.02 | 20.96 | 21.88 |
| Current ratioi | 1.20 | 1.73 | 1.03 | 1.04 | 1.07 | 1.10 |
| Quick ratioi | 0.95 | 1.45 | 0.79 | 0.82 | 0.78 | 0.78 |
| Debt / assetsi | 45.21 | 50.77 | 52.85 | 50.37 | 50.26 | 49.99 |
| LT debt / equityi | 371.05 | 413.26 | 381.61 | 368.63 | 350.20 | 331.55 |
| Interest coveragei | 9.61 | 10.47 | 9.64 | 8.81 | 7.73 | 7.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Products and Systems Integration is the largest reported line at 60.90% of revenue, across 2 reported segments.
- Software and Services follows at 39.10%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Products and Systems Integration60.90%
Software and Services39.10%
Quote time 2026-10-08 08:34:26 · For reference only, not investment advice and not tailored to your situation.